ASTRO announces 2009 Fellows

July 29, 2009

The American Society for Radiation Oncology is pleased to announce its 2009 class of ASTRO Fellows. These 12 distinguished members will receive their awards at a special ceremony during the 51th Annual Meeting being held November 1-5, 2009, at McCormick Place West in Chicago.

"It is an honor to be able to recognize these outstanding individuals who have devoted their careers to improving the specialty of radiation oncology and the care that cancer patients receive and who also have devoted their free time to serving the Society in leadership roles," Patricia Eifel, M.D., FASTRO, ASTRO chairman and a professor of radiation oncology at the University of Texas M.D. Anderson Cancer Center in Houston, said. "Everyone in this year's Fellows class is very deserving of this distinction."

Members of ASTRO are eligible to become a Fellow if they have been part of the Society for at least 20 years, have served in a leadership role for the organization and have made a significant contribution to the field of radiation oncology. The primary pathways to becoming a Fellow are excellence in research, patient care, education and leadership/service. The Society values contributions to all four areas; however, each nominee needed to have a truly outstanding contribution to at least one of the pathways to be named a Fellow.

The nominations were reviewed by the nine-member Fellows Selection Committee who made recommendations to the ASTRO Board of Directors to make the final decision.

The 2009 ASTRO Fellows are:

Ross Abrams, M.D., Rush University, Chicago

Beatriz E. Amendola, M.D., Innovative Cancer Institute, South Miami, Fla.

Mark W. Dewhirst, D.V.M., Ph.D., Duke University Medical Center, Durham, N.C.

Ronald V. Dorn III, M.D., Mountain States Tumor Institute, Boise, Idaho

Carolyn R. Freeman, M.B., B.S., McGill University Health Centre, Montreal, Canada

Joseph S. Kong, M.D., Cancer Center of Southeast Texas, Port Arthur, Texas

Jay S. Loeffler, M.D., Massachusetts General Hospital, Boston

Minesh P. Mehta, M.D., University of Wisconsin School of Medicine, Madison, Wis.

James B. Mitchell, Ph.D., National Cancer Institute, Bethesda, Md.

John E. Moulder, Ph.D., Medical College of Wisconsin, Milwaukee

Sara Rockwell, Ph.D., Yale University School of Medicine, New Haven, Conn.

Jeffrey Y.C. Wong, M.D., City of Hope Cancer Center, Duarte, Calif.
-end-
For more information on ASTRO's 51th Annual Meeting, visit www.astro.org. To learn more about radiation therapy treatments, visit www.rtanswers.org.

ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy. For more information on radiation therapy, visit www.rtanswers.org. To learn more about ASTRO, visit www.astro.org.

American Society for Radiation Oncology

Related Cancer Center Articles from Brightsurf:

Yale Cancer Center study validates combination therapy for aggressive endometrial cancer
Yale Cancer Center (YCC) scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

UA Cancer Center research team explores anti-breast cancer properties of soy
Genistein, a major compound in soy foods, might aid in the proper functioning of a gene that can malfunction to cause breast cancer.

UA Cancer Center team identifies a switch that may help target dormant cancer cells
Cells can enter a dormant state called quiescence, and dormant cancer cells are resistant to chemotherapy and other treatments.

CU Cancer Center study may explain failure of retinoic acid trials against breast cancer
'What has been missing in clinical trials may just be the timing of the treatments,' says first author Lynsey Fettig.

UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.

UA Cancer Center team questions safety, efficacy of selenium and colorectal cancer risk
Selenium has been a popular nutritional supplement for decades, touted for its antioxidant properties and its role in stopping free radicals from damaging cells and DNA.

UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.

Moffitt Cancer Center awarded $3.4 million grant to establish imaging biomarker validation center
Early detection is one of the most effective strategies to save lives from most cancers.

NYU's Perlmutter Cancer Center & the Technion launch global cancer research initiative
Drug-carrying 'nanoghosts' that battle melanoma and new treatments for malignant mesothelioma will be the focus of the first joint research projects led by NYU Langone Medical Center and the Technion-Israel Institute of Technology.

Read More: Cancer Center News and Cancer Center Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.